You are here
Alerts
This page shows all our alerts. These are Safety alerts, Medicine shortage alerts and Product recalls. You can sort the list with the filters on the left, use the search bar or both.
For more information see Product safety.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Alert/Advisory (1123)
- Medicines safety (501)
- Medical devices safety (342)
- Shortages (77)
- Safety (52)
- Prescription medicines (46)
- Regulatory compliance (18)
- Import and export (16)
- Listed medicines (14)
- Over the counter (OTC) medicines (12)
- Complementary medicines (10)
- Therapeutic goods regulation (10)
- Blood safety (8)
- Non-prescription medicines (6)
- Australian Register of Therapeutic Goods (ARTG) (5)
- Advertising (3)
- Sunscreens (3)
- Breast implant hub (2)
- Labelling and packaging (2)
- Legislation (2)
- Assessed listed medicines (1)
- Clinical trials (1)
- Compliance and enforcement hub (1)
- Metal-on-metal hip replacement implants hub (1)
- Registered complementary medicines (1)
Type of content
Results for
"[search-keyword]"
Search
1324 result(s) found, displaying 26 to 50
-
Medicine shortage alertsFind out about the shortage of Orencia (abatacept) 125 mg/mL ClickJect autoinjector and prefilled syringe for subcutaneous injection.
-
Medicine shortage alertsAll strengths of Vyvanse capsules are now available.
-
Safety alertsDark Horse Capsules pose a serious risk to your health and should not be taken.
-
Recall actionsIf the dosing syringe is stiff and difficult to use, you may not be able to control the delivery of the medicine. This poses a risk of choking, especially for babies.
-
Medicine shortage alertsShortages of both Orencia (abatacept) 125 mg products, the ClickJect prefilled autoinjector and prefilled syringe for subcutaneous injection, are anticipated from early to mid-June 2024. Find out more.
-
Medicine shortage alertsThis shortage has been extended
-
Medicine shortage alertsThe shortage of Vyvanse 60 mg has been extended to 30 April 2024
-
Medicine shortage alertsPfizer Australia has advised that the shortage of Bicillin L-A prefilled syringe for injection will continue until mid-2024, so we have approved the importation and supply of a second overseas-registered product, Extencilline benzathine benzylpenicillin 1.2 million unit vial (France), until 30 September 2024.
-
Recall actionsBe alert to the issue of unexpected shut down of the A30 and A40 series bi-level positive airway pressure (BiPAP) devices. This can cause interruptions and loss of therapy for patients.
-
Recall actionsBe alert about a higher risk of device failure with the Hintermann Series H3 Total Ankle Replacement (TAR) system. Read this if you're a patient, carer or health care provider.
-
Recall actionsThe companies supplying Fanttest COVID-19 test kits were made aware of the potential for variability in the way the control line appears (ie a weak/faint/pale control line) when strong COVID-19 positive results are obtained.
-
Safety alertsThe product tested is not listed in the ARTG and has not been assessed by the TGA for quality, safety or efficacy as required under Australian legislation.
-
Recall actionsSun Herbal Pty Ltd is recalling Clear the Skin Formula a.k.a. Liang Xue Xiao Feng San CM116, a Chinese medicine for skin rash because the label does not display the required warning statement.
-
Medicine shortage alertsMetalyse (tenecteplase) 40 mg for injection is to be discontinued; supply of Metalyse 50 mg for injection is not affected.
-
Medicine shortage alertsThe shortages of these products have been extended by the sponsor.
-
Medicine shortage alertsInformation has been updated about the ongoing shortages of Vyvanse medicines
-
Medicine shortage alertsWe have made a legal instrument to allow substitution between gliclazide medicines
-
Medicine shortage alertsInformation about the change in market authorisation for Ordine (morphine) oral liquid products
-
Safety alertsRead our safety advisory for Medicines containing Withania somnifera (Withania, Ashwagandha). Be aware of potential gastrointestinal symptoms and very rare cases of liver injury.
-
Medicine shortage alertsThe shortage of Zactin Tabs has been extended, there are management actions in place.
-
Safety alertsArtri King tablets pose a serious risk to your health and should not be taken.
-
Recall actionsThere have been reports of the dose counter stopping after the 10th dose and not locking after the 60th dose. If this happens, you should return the product to your place of purchase or contact Boehringer Ingelheim.
-
Safety alertsBullblood tablets pose a serious risk to your health and should not be taken.
-
Safety alertsCommander Stamina Time tablets pose a serious risk to your health and should not be taken.
-
Safety alertsExcite for her tablets pose a serious risk to your health and should not be taken.